Medtronic (MDT) is exploring options to optimize its global manufacturing operations in order to mitigate the impact of US President Donald Trump's tariff plans, Reuters reported Tuesday, citing the company's chief technology officer, Ken Washington.
The medical device maker has been closely monitoring Trump's tariff plans due to its presence in Mexico, which houses Medtronic's third largest manufacturing facility, the report said.
This comes after Trump imposed 25% duties on imports from Mexico and Canada that were to become effective early this month, but have been delayed until March 4 pending negotiations with the two countries.
Washington did not mention whether India was also part of the strategy to refine manufacturing operations, where the company launched its largest research and developmental center outside of the US in 2021, Reuters reported.
The company did not immediately respond to MT Newswires' request for comment on the matter.
(Market Chatter news is derived from conversations with market professionals globally. This information is believed to be from reliable sources but may include rumor and speculation. Accuracy is not guaranteed.)
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。